Loading data
SLXNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development expense | 7.14 m USD | 5.82 m USD | 3.71 m USD | 3.23 m USD |
| Operating profit | -11.63 m USD | -12.57 m USD | -4.68 m USD | -3.86 m USD |
| Profit before tax | -11.91 m USD | -16.51 m USD | -5.08 m USD | -3.46 m USD |
| Income tax expense | 3 k USD | 10 k USD | 32 k USD | 24 k USD |
| Net income (reported basis) | -11.91 m USD | -16.52 m USD | -5.11 m USD | -3.49 m USD |
| Net income attributable to common shareholders | 11.91 m USD | 16.44 m USD | 4.94 m USD | 3.22 m USD |
| Basic earnings per share | 89.61 USD/share | 3,955.11 USD/share | 659.55 USD/share | 28.79 USD/share |
| Diluted earnings per share | 89.61 USD/share | 3,955.11 USD/share | 659.55 USD/share | 28.79 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.